Travel Insurance After Cancer UK: What Is Available

Cover is possible at most stages of a cancer journey

A cancer diagnosis does not automatically rule out travel insurance. The market broadly distinguishes three situations: people who have completed treatment and are in remission, people under active or ongoing treatment, and people with advanced or palliative diagnoses. Each is insurable somewhere, but the route and the premium differ markedly.

For those who finished treatment some time ago and have been discharged or are on routine follow-up, even some mainstream insurers will offer cover after screening. The longer and more stable the period since active treatment ended, the easier the underwriting tends to be, because the risk of an acute event abroad falls.

For people under active treatment, awaiting results, or with a recently changed treatment plan, the specialist market is usually the right route. Specialist medical travel insurers underwrite cancer in detail and can often quote even where a high-street insurer declines, because they price the specific diagnosis, stage and treatment rather than refusing outright.

What the cancer screening covers

The medical screening for cancer is more detailed than for many conditions. It typically asks the type of cancer, when it was diagnosed, the stage or whether it has spread, the treatment received (surgery, chemotherapy, radiotherapy, hormone therapy, immunotherapy), whether treatment is ongoing or complete, and whether you are awaiting any tests, scans or results.

You must answer every question fully and accurately. Declare the primary cancer, any secondary spread, all current and recent treatment, any other conditions that have arisen from treatment, and any pending investigations. The duty under the Consumer Insurance (Disclosure and Representations) Act 2012 is to take reasonable care not to make a misrepresentation, and cancer is precisely the kind of history where omission can be costly.

If the screening asks whether you are awaiting results and you are, say so. A pending scan or biopsy is one of the most significant items for an insurer because the underlying picture is not yet settled, and answering it honestly is what keeps your cover reliable if you need to claim.

Why honesty protects you when it matters most

The proportionate remedies in the 2012 Act mean the consequence of a misrepresentation depends on whether it was innocent, careless or deliberate. An honest and reasonable answer that later proves incomplete should not defeat a claim. A careless misrepresentation allows the insurer to apply proportionate remedies. A deliberate or reckless one allows the policy to be voided and the claim refused.

With cancer, the stakes of getting this wrong are high because oncology emergencies abroad and repatriation can be extremely expensive. An undeclared cancer history that contributes to a claim is the scenario insurers most often cite when refusing payment, so full declaration is the single most important protection you have.

Keep the screening confirmation the insurer issues. It records exactly what you declared and is strong evidence that you answered the questions honestly if a claim is ever questioned. Pair it with your oncology letters and treatment summaries so you can demonstrate the accuracy of your declaration.

Specialist routes and what to expect on price

• Specialist medical insurers: underwrite cancer in detail and can quote during treatment, in remission or with advanced diagnoses.
• Signposting: if a mainstream insurer declines or loads heavily, FCA rules require it to direct you to specialist providers via the MoneyHelper directory.
• Destination and trip length: long-haul and cruise itineraries are harder to underwrite because of distance from advanced oncology care.
• Cancellation cover: declaring the cancer also matters for cancellation claims if treatment plans change before departure.

Premiums for active or advanced cancer can be high, and some policies exclude claims arising from the cancer while covering unrelated emergencies, baggage and cancellation. Read any cancer-related exclusion carefully so you understand whether an oncology event abroad would be covered or carved out, and whether the cover still meets your needs.

If a cancer-related claim is declined

If a claim connected to your cancer is refused or reduced, ask the insurer in writing which screening answer it relied on and how it categorised any misrepresentation under the 2012 Act. The firm should be able to explain whether it treated the issue as careless or deliberate and why.

If you disagree with the firm's final response, or eight weeks pass without resolution, you can escalate free of charge to the Financial Ombudsman Service. The FOS examines whether the screening question was clear, whether your answer was reasonable, and whether the correct proportionate remedy was applied.

The FOS publishes data on travel insurance complaints and outcomes. Where a question was ambiguous or a misrepresentation was genuinely innocent, the ombudsman frequently asks insurers to reconsider, so retaining your screening confirmation and oncology records is valuable if you ever need to challenge a decision.

Frequently asked questions

Can I get travel insurance while still having chemotherapy?

It is sometimes possible, usually through specialist medical travel insurers who underwrite active treatment in detail. Cover and price depend on the cancer type, stage and your fitness to travel, and any pending tests must be declared.

Do I still need to declare cancer if I have been in remission for years?

Yes. The Consumer Insurance (Disclosure and Representations) Act 2012 requires accurate answers to the screening questions regardless of how long ago treatment ended. A long, stable remission is often easier to insure, but only if declared.

What if I am waiting for scan results when I buy cover?

You must declare that you are awaiting results. Pending investigations are highly significant to insurers, and failing to mention them is exactly the kind of omission that can lead to a refused claim later.

Why did a mainstream insurer refuse me?

High-street insurers often decline active or advanced cancer because the risk is hard to price. Under FCA signposting rules they must direct you to specialist providers, listed in the MoneyHelper medical travel insurance directory.

Does a GHIC cover cancer treatment abroad?

A GHIC gives access to state healthcare in the EU but does not cover repatriation, private oncology care or cancellation costs, so it cannot replace proper travel insurance for someone with a cancer history.